Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous

Islam Y Elgendy1, Xuerong Wen1, Ahmed Mahmoud1

  • 1Department of Medicine, University of Florida, Gainesville, Florida.

Insights

Complete revascularization during primary percutaneous coronary intervention (PCI) reduces major adverse cardiac events (MACE) and urgent revascularization. This strategy is safe, showing no increased risk of bleeding or kidney issues in STEMI patients with multi-vessel disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Conflicting evidence exists regarding optimal revascularization strategy during primary percutaneous coronary intervention (PCI).
  • Optimal management of multi-vessel disease in ST-elevation myocardial infarction (STEMI) remains debated.

Purpose of the Study:

  • To determine if complete revascularization of significant coronary lesions during primary PCI improves patient outcomes compared to culprit-only revascularization.
  • To update meta-analysis findings on revascularization strategies in STEMI patients.

Main Methods:

  • Meta-analysis of randomized clinical trials comparing complete versus culprit-only revascularization in STEMI patients with multi-vessel disease.
  • Utilized random effects models to calculate summary risk ratios (RR) for key outcomes.
  • Primary outcome assessed was the composite of mortality or myocardial infarction (MI).

Main Results:

  • Seven trials including 1,939 patients were analyzed.
  • Complete revascularization showed a non-significant trend towards reduced mortality or MI (RR 0.69, P=0.14).
  • Significant reduction in major adverse cardiac events (MACE) (RR 0.61, P<0.001) and urgent revascularization (RR 0.46, P<0.001) observed with complete revascularization.
  • No significant difference in major bleeding or contrast-induced nephropathy between strategies.

Conclusions:

  • Complete revascularization of all significant coronary lesions during primary PCI reduces MACE, primarily by decreasing urgent revascularization.
  • This approach is safe and does not increase the risk of major bleeding or contrast-induced nephropathy.
  • Complete revascularization is a favorable strategy for STEMI patients with multi-vessel disease.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
400
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
559
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.6K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
450
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
426